Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol
Roderick Skinner,
Leontien C M Kremer,
Anne Blondeel,
Samira Essiaf,
Gisela Michel,
Tomas Kepak,
Riccardo Haupt,
Jeanette F Winther,
Lars Hjorth,
Joke C Korevaar,
Saskia M F Pluijm,
Katharina Roser,
Mieke Rijken,
Renée L Mulder,
Helena J H van der Pal,
Rosella P M G Hermens,
Stefan Boes,
Rebecca J van Kalsbeek,
Monica Muraca,
Katerina Kepakova,
Line E Frederiksen,
Anita Kienesberger,
Jacqueline J Loonen,
Kylie B O'Brien,
Marleen Renard,
Anne Uyttebroeck,
Cecilia Follin
Affiliations
Roderick Skinner
13 Paediatric Haematology, Great North Children`s Hospital, Newcastle upon Tyne, UK
Leontien C M Kremer
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Anne Blondeel
Department of Scientific Programme Coordination, European Society for Paediatric Oncology (SIOPE), Brussels, Belgium
Samira Essiaf
Department of Scientific Programme Coordination, European Society for Paediatric Oncology (SIOPE), Brussels, Belgium
Gisela Michel
Swiss Paediatric Respiratory Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Tomas Kepak
73 University Hospital Brno, Masaryk University and ICRC/St. Anna University Hospital, Brno, Czech Republic
Riccardo Haupt
Epidemiology and Biostatistics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
Jeanette F Winther
Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
Lars Hjorth
Skåne University Hospital Lund, Lund, Sweden
Joke C Korevaar
Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands
Saskia M F Pluijm
3Department of Pediatric Hemato-Oncology, Erasmus University Medical Center, Rotterdam, Netherlands
Katharina Roser
Careers Division, Swiss National Science Foundation, Bern, Switzerland
Mieke Rijken
Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands
Renée L Mulder
Department of Paediatric Oncology, Emma Children`s Hospital/Academic Medical Center, Amsterdam, The Netherlands
Helena J H van der Pal
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Rosella P M G Hermens
Scientific Institute for Quality of Healthcare, Radboudumc, Nijmegen, The Netherlands
Stefan Boes
Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
Rebecca J van Kalsbeek
Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands
Monica Muraca
DOPO Clinic, Department of Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Katerina Kepakova
International Clinical Research Centre (FNUSA-ICRC) at St Anne’s University Hospital, Masaryk University Faculty of Medicine, Brno, Czech Republic
Line E Frederiksen
Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
Anita Kienesberger
Childhood Cancer International Europe, Vienna, Austria
Jacqueline J Loonen
Department of Hematology, Radboudumc, Nijmegen, The Netherlands
Kylie B O'Brien
Pintail, Limited, Dublin, Ireland
Marleen Renard
Department of Paediatric Haematology and Oncology, KU Leuven, University Hospitals Leuven, Leuven, Belgium
Anne Uyttebroeck
Department of Paediatric Haematology and Oncology, KU Leuven, University Hospitals Leuven, Leuven, Belgium
Cecilia Follin
Department of Clinical Sciences Lund, Oncology, Lund University, Skane University Hospital, Lund, Sweden
Introduction Long-term survival after childhood cancer often comes at the expense of late, adverse health conditions. However, survivorship care is frequently not available for adult survivors in Europe. The PanCareFollowUp Consortium therefore developed the PanCareFollowUp Care Intervention, an innovative person-centred survivorship care model based on experiences in the Netherlands. This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries.Methods and analysis In this prospective, longitudinal cohort study with at least 6 months of follow-up, 800 childhood cancer survivors will receive the PanCareFollowUp Care Intervention across four study sites in Belgium, Czech Republic, Italy and Sweden, representing different healthcare systems. The PanCareFollowUp Care Intervention will be evaluated according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Clinical and research data are collected through questionnaires, a clinic visit for multiple medical assessments and a follow-up call. The primary outcome is empowerment, assessed with the Health Education Impact Questionnaire. A central data centre will perform quality checks, data cleaning and data validation, and provide support in data analysis. Multilevel models will be used for repeated outcome measures, with subgroup analysis, for example, by study site, attained age, sex or diagnosis.Ethics and dissemination This study will be conducted in accordance with the guidelines of Good Clinical Practice and the Declaration of Helsinki. The study protocol has been reviewed and approved by all relevant ethics committees. The evidence and insights gained by this study will be summarised in a Replication Manual, also including the tools required to implement the PanCareFollowUp Care Intervention in other countries. This Replication Manual will become freely available through PanCare and will be disseminated through policy and press releases.Trial registration number Netherlands Trial Register (NL8918; https://www.trialregister.nl/trial/8918).